All times listed are Central Time Zone.
| 8:00 AM |
Breakfast & Check-in |
| 9:00 AM |
Welcome William Gradishar, MD |
|
SESSION 1
Issues in Survivorship Session Moderator: Patricia Robinson, MD | |
| 9:05 AM |
What’s New in Lymphedema Risk Assessment, Evaluation, and Management? Sarah McLaughlin, MD |
| 9:35 AM |
Immediate Lymphatic Reconstruction for Lymphedema Prevention and Treatment Michelle Coriddi, MD |
| 10:05 AM |
Survivorship Issues in Young Women Sheetal Kircher, MD |
| 10:35 AM |
Breast Screening in Transgender Patients Sarah Friedewald, MD |
| 11:05 AM |
What’s New in Exercise Oncology Lee Jones, PhD |
| 11:35 AM |
Q&A |
| 11:55 AM |
Lunch |
|
SESSION 2
Breast Pathology for the Non-Pathologist Session Moderator: Kalliopi Siziopikou, MD, PhD | |
| 1:00 PM |
Artificial Intelligence (AI) applications in Breast Pathology Lee Cooper, PhD |
| 1:30 PM |
Spindle Cell Lesions of the Breast Indu Agarwal, MD |
| 2:00 PM |
Breast Pathology in Transgender Individuals Molly Klein, MD |
| 2:30 PM |
Beyond BRCA: Pathologic Features of Breast Carcinomas Associated with Other Genes Conferring Breast Cancer Risk Kalliopi Siziopikou, MD, PhD |
| 3:00 PM |
Q&A |
| 3:20 PM |
Break |
| 3:40 PM |
Unusual Cases Panel Moderator: William Gradishar, MD; Panel: Jacob Bermudez, MD, Luis Blanco, Jr., MD; Lisa Flaum, MD; Susan Gerber, MD; Janice Lu, MD, PhD; Jonathan Strauss, MD, MBA; Jeanne Wirpsa, MA, BCC, HEC-C |
| 5:00 PM |
Awards |
| 5:15 PM |
Adjourn |
|
View more agendas: Thursday | Friday | Saturday | Sunday | |
| 7:30 AM |
Breakfast |
|
SESSION 3
Imaging & Risk Session Moderator: Nora Hansen, MD | |
| 8:30 AM |
Polygenic Risk Scores: Ready for Primetime? Claudine Isaacs, MD |
| 9:00 AM |
Genetic Risk Evaluation after Breast Cancer Diagnosis: Promise vs Practice Steven Katz, MD |
| 9:30 AM |
AI in Breast Imaging: Where Are We Now? Emily Conant, MD |
| 10:00 AM |
Break |
| 10:20 AM |
Vaccines for Prevention and Treatment Elizabeth Mittendorf, MD |
| 10:50 AM |
Q&A |
| 11:10 AM |
LYNN SAGE DISTINGUISHED LECTURE Biology Directed Radiotherapy in Breast Cancer Timothy Whelan, MD |
| 12:10 PM |
Lunch |
|
SESSION 4
Controversies in Hormone Receptor Positive Breast Cancer Session Moderator: Jonathan Strauss, MD | |
| 1:30 PM |
Ovarian Function Suppression: When is it Indicated? Karen Gelmon, MD |
| 2:00 PM |
Current Status of Immunotherapy in HR+ Breast Cancer Rita Nanda, MD |
| 2:30 PM |
Is RT Necessary in Postmenopausal HR+ Women at Low Genomic Risk? Reshma Jagsi, MD |
| 3:00 PM |
Break |
| 3:20 PM |
Breast Cancer in Older Women Christina Minami, MD |
| 3:50 PM |
Improving Options in HR+ Metastatic Cancer William Gradishar, MD |
| 4:20 PM |
Q&A |
| 4:45 PM |
Adjourn |
| 4:45 PM |
Reception Sponsored by: Biotheranostics, a Hologic Company |
|
View more agendas: Thursday | Friday | Saturday | Sunday | |
| 7:30 AM |
Breakfast |
|
SESSION 5
Factors Informing Treatment and Management of Early-Stage Disease Session Moderator: Janice Lu, MD, PhD | |
| 8:30 AM |
What’s New in DCIS? Tari King, MD |
| 9:00 AM |
Radiation Therapy in DCIS: Factors to Consider Seema Khan, MD |
| 9:30 AM |
Targeted Therapy and Endocrine Therapy Fred Howard, MD |
| 10:00 AM |
Management of the HER2+ Patient in 2024 Charles Geyer, MD |
| 10:30 AM |
Break |
| 11:00 AM |
Intensive Surveillance: Is it Warranted? Pro: Ricardo Costa, MD, MSc | Con: Virginia Kaklamani, MD, DSc |
| 11:30 AM |
Q&A |
| 12:00 PM |
Lunch |
|
SESSION 6
Tailoring Local Therapy Session Moderator: Monica Morrow, MD | |
| 1:15 PM |
Phyllodes Tumors Laura Rosenberger, MD |
| 1:45 PM |
TILS Today Sunil Badve, MD |
| 2:15 PM |
When Can Axillary Staging be Eliminated? Monica Morrow, MD |
| 2:35 PM |
When is Axillary Staging Necessary? Armando Giuliano, MD |
| 2:55 PM |
Q&A |
| 3:25 PM |
Case Management Panel Moderator: Monica Morrow, MD. Panel: Armando Giuliano, MD; William Gradishar, MD; John Hayes, MD; Virginia Kaklamani, MD, DSc; |
| 5:00 PM |
Adjourn |
|
View more agendas: Thursday | Friday | Saturday | Sunday | |
| 7:30 AM |
Breakfast |
|
SESSION 7
Questions, Controversies and Future Directions Session Moderator: Bill Gradishar, MD | |
| 8:30 AM |
Isolated Tumor Cells: Clinical and Prognostic Implications Andrea Barrio, MD |
| 9:00 AM |
Radiation Therapy after NAC: NSABP B51 Terry Mamounas, MD |
| 9:30 AM |
Stage 1 HER2+ and TN Cancer: Surgery First or NAC? Anita Mamtani, MD |
| 10:00 AM |
cTDNA: Current Status Ben Park MD, PhD |
| 10:30 AM |
Q&A |
| 11:00 AM |
Adjourn |
|
View more agendas: Thursday | Friday | Saturday | Sunday | |
The Lurie Cancer Center's Lynn Sage Breast Cancer Symposium offers 3 days of formal presentations and interactive Q&A sessions.
The Lynn Sage Breast Cancer Symposium is proud of its tradition of attracting a faculty comprised of experts from around the world. Faculty list
Optional, non-CME educational activities are scheduled during times that do not conflict with the Symposium agenda.
